Prevalence of function‐limiting late effects in survivors of head and neck cancer
PM&R · 2025-06 · 17 (6) · 654-662
DOI: 10.1002/pmrj.13340 ↗Kurz gefasst
Fachartikel in der Zeitschrift PM&R, online erschienen am 26.02.2025. Verfasst von Yu Hui Won und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, Jeonbuk National University Medical School, Jeonju, South Korea. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Quality of Life, Cancer Survivors, Neuromuscular Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Survivors of head and neck cancer (HNC) are commonly affected by multiple complex and interrelated long‐term and late effects that can adversely affect their function and quality of life.
Objective
To define the prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects affecting function and quality of life in survivors of HNC.
Design
Retrospective cohort analysis.
Setting
Outpatient cancer rehabilitation clinic at a physical medicine and rehabilitation hospital that includes a freestanding inpatient rehabilitation unit along with an outpatient clinic.
Participants
One hundred thirty survivors of HNC who sought specialized cancer rehabilitation services to address complex functional impairments.
Interventions
Not applicable. Main Outcome Measures Prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects affecting function and quality of life in survivors of HNC.
Results
The majority underwent surgery (53.8%), chemotherapy (22.3%), and radiation therapy (93.8%) as part of their treatment. Neuromuscular complications such as myelopathy (45.4%), radiculoplexopathy (58.5%), mononeuropathy (84.6%), and myopathy (57.7%) were prevalent. Musculoskeletal impairments included dysphagia (92.3%), dysarthria (60.8%), trismus (40.8%), cervical dystonia (47.7%), and shoulder dysfunction (27.7%). Visceral disorders encompassed lymphedema (86.2%), hypothyroidism (26.2%), and baroreceptor failure (19.2%). Additionally, oncologic complications, including recurrence (18.5%), metastasis (5.4%), and secondary malignancies (8.5%) were observed. Pain (74.6%) and fatigue (31.5%) were reported as major function‐limiting impairments. Most survivors (96.9%) were referred to therapy including physical therapy (85.4%), occupational therapy (13.1%), speech‐language pathology (84.6%), and lymphedema therapy (72.3%). Most (85.4%) required two or more therapy disciplines.
Conclusion
Survivors of HNC accessing cancer rehabilitation services commonly present with diverse, complex, and interrelated neuromuscular, musculoskeletal, visceral, and oncologic late effects that can severely affect function and quality of life. Comprehensive rehabilitation should include evaluation and management of these complex and interrelated late effects by a rehabilitation team that includes cancer rehabilitation physicians, physical therapists, occupational therapists, lymphedema therapists, and speech‐language pathologists, among others.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Physical Medicine and Rehabilitation, Jeonbuk National University Medical School, Jeonju, South Korea.
- Research Institute of Clinical Medicine of Jeonbuk National University, BiomedicalResearch Institute of Jeonbuk National University Hospital, Jeonju, South Korea.
- Medical Director for Cancer Rehabilitation, Kessler Institute for Rehabilitation, West Orange, New Jersey, USA.
- Medical Director for Complex Medical Rehabilitation for the Inpatient Rehabilitation Hospital Division, Select Medical, Mechanicsburg, PA, USA.
- Medical Director for ReVital Cancer Rehabilitation, Select Medical, Mechanicsburg, PA, USA.
- Department of Physical Medicine and Rehabilitation, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
ORCID-Profile: Yu Hui Won
Zitieren
APA
Won, Y. H., & Stubblefield, M. D. (2025). Prevalence of function‐limiting late effects in survivors of head and neck cancer. PM&R, 17(6), 654-662. https://doi.org/10.1002/pmrj.13340
Vancouver
Won YH, Stubblefield MD. Prevalence of function‐limiting late effects in survivors of head and neck cancer. PM&R. 2025;17(6):654-662. doi:10.1002/pmrj.13340
BibTeX
@article{Won2025,
author = {Won, Yu Hui and Stubblefield, Michael D},
title = {Prevalence of function‐limiting late effects in survivors of head and neck cancer},
journal = {PM&R},
year = {2025},
volume = {17},
number = {6},
pages = {654--662},
doi = {10.1002/pmrj.13340}
}
EUVIMED